Compare ICLR & FDS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ICLR | FDS |
|---|---|---|
| Founded | 1990 | 1978 |
| Country | Ireland | United States |
| Employees | N/A | 6258 |
| Industry | Biotechnology: Commercial Physical & Biological Resarch | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.3B | 9.1B |
| IPO Year | 2001 | 1996 |
| Metric | ICLR | FDS |
|---|---|---|
| Price | $172.23 | $299.91 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 13 | 11 |
| Target Price | $178.62 | ★ $284.80 |
| AVG Volume (30 Days) | ★ 805.3K | 736.1K |
| Earning Date | 05-12-2026 | 03-31-2026 |
| Dividend Yield | N/A | ★ 1.89% |
| EPS Growth | N/A | ★ 11.79 |
| EPS | N/A | ★ 11.16 |
| Revenue | N/A | ★ $1,435,351,000.00 |
| Revenue This Year | N/A | $7.16 |
| Revenue Next Year | N/A | $5.55 |
| P/E Ratio | ★ $12.91 | $26.89 |
| Revenue Growth | N/A | ★ 6.31 |
| 52 Week Low | $66.57 | $185.00 |
| 52 Week High | $203.91 | $386.52 |
| Indicator | ICLR | FDS |
|---|---|---|
| Relative Strength Index (RSI) | 57.57 | 64.07 |
| Support Level | $172.65 | $267.36 |
| Resistance Level | $188.49 | $300.77 |
| Average True Range (ATR) | 6.78 | 9.79 |
| MACD | 0.57 | 1.06 |
| Stochastic Oscillator | 73.21 | 84.02 |
Icon is a global contract research organization that provides outsourced clinical development services to pharmaceutical and biotechnology firms. Icon supports clients across late-stage clinical trials through the regulatory approval process and postmarket studies. Icon's services include clinical trial management, patient recruitment, data analytics, laboratory services, and regulatory consulting. With more than 40,000 employees operating in over 50 countries, the company partners with life sciences firms to run clinical trials and bring new drugs to market.
FactSet provides financial data and portfolio analytics to the global investment community. The company aggregates data from third-party data suppliers, news sources, exchanges, brokerages, and contributors into its workstations. In addition, it provides essential portfolio analytics that companies use to monitor portfolios and address reporting requirements. Buy-side clients (including wealth and corporate clients) account for over 80% of FactSet's annual subscription value. In 2015, the company acquired Portware, a provider of trade execution software. In 2017, it acquired BISAM, a risk management and performance measurement provider. In 2022, it completed its purchase of CUSIP Global Services.